Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
The clinical effects of inclisiran, a first-in-class LDL-C lowering siRNA therapy, on the LDL-C levels in Chinese patients with hypercholesterolemia.
Journal: Journal of clinical lipidology
Published: January 27, 2023
Non-invasive candidate protein signature predicts hepatic venous pressure gradient reduction in cirrhotic patients after sustained virologic response.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: January 23, 2023
Preclinical characterization of AB-506, an inhibitor of HBV replication targeting the viral core protein.
Journal: Antiviral research
Published: August 28, 2021
Host Poly(A) Polymerases PAPD5 and PAPD7 Provide Two Layers of Protection That Ensure the Integrity and Stability of Hepatitis B Virus RNA.
Journal: Journal of virology
Published: June 30, 2021
The Dihydroquinolizinone Compound RG7834 Inhibits the Polyadenylase Function of PAPD5 and PAPD7 and Accelerates the Degradation of Matured Hepatitis B Virus Surface Protein mRNA.
Journal: Antimicrobial agents and chemotherapy
Published: April 02, 2020
The E3 ligase TRIM56 is a host restriction factor of Zika virus and depends on its RNA-binding activity but not miRNA regulation, for antiviral function.
Journal: PLoS neglected tropical diseases
Published: September 25, 2018
Preclinical Profile of AB-423, an Inhibitor of Hepatitis B Virus Pregenomic RNA Encapsidation.
Journal: Antimicrobial agents and chemotherapy
Published: January 17, 2018
Enhancing the antiviral potency of ER α-glucosidase inhibitor IHVR-19029 against hemorrhagic fever viruses in vitro and in vivo.
Journal: Antiviral research
Published: October 03, 2017
Identification of Residues Controlling Restriction versus Enhancing Activities of IFITM Proteins on Entry of Human Coronaviruses.
Journal: Journal of virology
Published: September 21, 2017
HBsAg mRNA degradation induced by a dihydroquinolizinone compound depends on the HBV posttranscriptional regulatory element.
Journal: Antiviral research
Published: August 06, 2017
HBV core protein allosteric modulators differentially alter cccDNA biosynthesis from de novo infection and intracellular amplification pathways.
Journal: PLoS pathogens
Published: June 27, 2017
Last Updated: 09/26/2026